1,814 product recalls found in this category. Browse through all safety alerts and stay informed.
High Activity Category
This category has a significant number of recalls. Please check regularly for updates.
Draeger, Inc. recalled 431 units of the Vapor 2000 anesthetic vaporizer on November 24, 2025. A component of the devices contained impurities and did not meet specifications, posing a high hazard risk. Healthcare providers and patients should cease use immediately and follow recall instructions.
Abbott Diabetes Care recalled over 1 million FreeStyle Libre 3 sensors on November 24, 2025, due to a manufacturing issue. The defect may lead to incorrect low glucose readings, posing a serious health risk. Affected sensors were distributed across the U.S. and several international markets.
Towa Pharmaceuticals recalled 3,397 bottles of Duloxetine Delayed-Release Capsules on November 24, 2025. The recall stems from CGMP deviations resulting in N-nitroso-duloxetine levels exceeding FDA limits. Consumers must stop using the product immediately.
Abbott Diabetes Care recalled 1,663,241 FreeStyle Libre 3 Plus sensors on November 24, 2025. A manufacturing issue may lead to incorrect low glucose results, creating serious health risks for users. Patients should stop using the sensors immediately and follow recall instructions.
Breckenridge Pharmaceutical, Inc. recalled 7,389 bottles of Duloxetine Delayed-Release Capsules on November 24, 2025. The recall stems from CGMP deviations and the presence of N-nitroso-duloxetine impurity above FDA limits. Consumers should stop using the product immediately and contact healthcare providers for guidance.
ICU Medical recalled LifeShield Drug Library Management software on November 24, 2025. A software issue limits concentration precision to one decimal place, risking incorrect drug dosages. Users should stop using the product immediately and follow recall instructions.
Draeger, Inc. recalled 188 units of the Vapor 3000 anesthetic vaporizer on November 24, 2025. The devices contained impurities in a component not delivered within specification. Healthcare providers and patients must stop using the devices immediately.
Abbott Diabetes Care recalled 258,913 FreeStyle Libre 3 Plus sensors on November 24, 2025. Manufacturing issues may lead to incorrect low glucose results, posing a high risk to users. Consumers should stop using the device immediately and follow the recall instructions.
ICU Medical recalled the LifeShield Infusion Safety Software Suite v2.2 on November 24, 2025. The software fails to operate as expected for migrated libraries, risking medication delivery errors. The recall affects seven customers across several states, including California and New York.
Changchun Wancheng Bio-Electron Co. recalled 1,000 Menopause Test Cassettes on November 22, 2025. The recall follows reports that the devices can produce false or inaccurate results, potentially leading to inappropriate medical interventions. Customers in Texas, Georgia, and California should stop using the test immediately and follow recall instructions.
Changchun Wancheng Bio-Electron Co. recalled 1,000 units of S. Typhi/Para Typhi A Antigen test strips on November 22, 2025. The recall affects tests distributed nationwide, which may produce false results and lead to inappropriate medical intervention.
LotFancy recalled 91,366 urinary tract infection test strips on November 22, 2025. The strips may produce false results, risking inappropriate medical intervention. Affected products include various models sold nationwide in states like Texas, Georgia, and California.
Changchun Wancheng Bio-Electron Co. recalled 32,500 Keto-pH-Uric Acid Test Strips on November 22, 2025. The strips may provide inaccurate results and lead to inappropriate medical intervention. The recall affects products distributed nationwide in Texas, Georgia, and California.
Changchun Wancheng Bio-Electron Co. recalled 1,000 LH One Step Ovulation Test Devices on November 22, 2025. The tests may deliver false or inaccurate results, potentially leading to inappropriate medical intervention. The recall affects U.S. consumers in Texas, Georgia, and California.
Changchun Wancheng Bio-Electron Co. recalled 1,000 male fertility sperm tests on November 22, 2025. The tests were distributed without proper FDA clearance and may yield inaccurate results. This could lead to inappropriate medical interventions by users.
Changchun Wancheng Bio-Electron Co. recalled 4,800 Exploro Male Fertility Tests on November 22, 2025. These devices may provide false diagnostic results, potentially leading to inappropriate medical interventions. Consumers should stop using the product immediately and follow recall instructions.
Changchun Wancheng Bio-Electron Co. recalled 500 Vivoo Protein Test strips on November 22, 2025. The devices may provide false diagnostic results, leading to inappropriate medical interventions. This recall affects consumers nationwide in Texas, Georgia, and California.
Changchun Wancheng Bio-Electron Co. recalled 500 Vivoo pH Test strips on November 22, 2025. The recall follows concerns over false diagnostic results that could lead to inappropriate medical interventions. These devices were distributed nationwide, including Texas, Georgia, and California.
Vivoo recalled 3,000 vaginal pH tests on November 22, 2025. The tests may cause false results leading to inappropriate medical interventions. The products were distributed nationwide, including Texas, Georgia, and California.
Changchun Wancheng Bio-Electron Co. recalled 3,300 Vivoo test strips on November 22, 2025. The devices may provide inaccurate results, leading to inappropriate medical actions. Affected products include sodium, Vitamin C, and hydration tests.